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Introduction
Gastrointestinal cancer surgery is associated with high rates of postoperative complications. It has been suggested that these complications may promote tumor recurrence and decrease long-term survival, particularly in colorectal cancer surgery [1] [2] [3] . This relationship appears to be stronger for infectious complications [4] . Conflicting results have been reported regarding the association between postoperative complications and poor survival after resection of oesophageal cancer [5] [6] [7] . A more consistent relationship, however, has recently been described for gastric cancer resection, mainly in series from Eastern Asia, although differences in classifying or grading complications make these results still unclear [8] [9] [10] [11] [12] . It appears plausible that these results can be extrapolated to Western series where the incidence of overall and infectious postoperative complications, as well as the percentage of cases with advanced stages (II-III) are higher as compared with Eastern Asia series [13] .
Clinical and experimental data suggest that persistent systemic inflammatory response by infectious complications may promote tumor recurrence and progression after cancer surgery [14, 15] . It is worthwhile to assess the impact of septic events (sepsis and intraabdominal sepsis) uniformly classified on the oncologic outcome of patients undergoing curative gastric cancer resection.
The purpose of the present study was to examine the effects of postoperative complications especially those associated with a systemic inflammatory response, on recurrence and long-term survival after curative surgery for gastric cancer.
Methods

Study population
Between January 1990 and December 2009, 315 consecutive patients with gastric adenocarcinoma underwent R0 resection at the Gastrointestinal Surgical Units of Hospital Universitario del Mar and Hospital Clínic, in Barcelona, Spain.
A specialized team following similar perioperative protocols over the time frame of the study performed gastric resection with associated lymphadenectomy.
Given the time span of patients included in the study, the extent of lymphadenectomy varied but D2 dissection without splenectomy was commonly performed. The Institutional Review and Boards of both participating hospitals approved data collection and analysis.
Clinicopathological data and follow-up status for all operated patients were collected from a prospectively maintained database, which was common to both institutions. Two experienced pathologists (M.I., M.C) re-reviewed all diffuse and mixed type adenocarcinomas to identify signet ring cell (SRC) types, defined according to World Health Organization criteria [16] . Tumors were reclassified according to the seventh UICC/TNM classification system [17] .
In the context of clinical trials carried out during the study period [18, 19] 
Definition of Postoperative Complications
Complications were categorized into five grades according to the modified Clavien-Dindo (CD) classification [20] . If multiple complications occurred, the higher grade was used. For the purpose of this study, patients with CD > II were considered as the "complication group". Additionally, the Comprehensive Complication Index (CCI) was calculated as the sum of all complications that are weighted for their severity [21] . The final formula yields a continuous scale to rank the severity of any combination of complications from 0 to 100 in a single patient.
Perioperative blood transfusion (PBT) was defined as transfusion of allogenic red blood cells from 30 days before surgery until hospital discharge [22] . Indication of blood transfusion was left to the discretion of the treating physician. Sepsis was defined as an infection that had evoked a systemic inflammatory response syndrome (SIRS) [23] . Respiratory septic complications included pneumonia (defined as new or progressive infiltrate on chest X-ray, accompanied by fever/leukocytosis or leukopenia and purulent sputum, for which antibiotics treatment was started) and pleural empyema. Wound infection was defined as purulent drainage from the deep or superficial incision. an indwelling urinary catheter and positive urine culture) was also considered.
Follow-up
All patients were seen at the outpatient clinic by a medical oncologist and a surgeon at 3 months intervals during the first 2 years after operation, and every 6 months thereafter for 3 years. After 5 years, patients were followed every Statistical significance was set at P < 0.05 (two-sided). The SPSS software package (SPSS Inc, Chicago, IL, USA), version 18.0, was used to manage patient data and to perform statistical analyses.
Results
Of the 315 eligible patients, 44 (14%) patients were excluded from the analysis for the following reasons: 18 received neoadjuvant therapy, 11 underwent surgery for gastric stump carcinoma, 6 patients presented with a synchronous primary tumor at the time of diagnosis, and 9 patients died before postoperative day 60. The demographic details and clinicopathological characteristics of the 271 patients finally included in the study are shown in Table1. PBT rate in the series was 45% (122 patients); only 7 patients received exclusively preoperative blood transfusion. In more than half of the patients with CD grade II (52%), PBT was the sole complication.
Complications
Sixty-six out of 271 patients (22.5%) developed 84 septic complications.
Intra-abdominal sepsis was the most common event (37 patients; 13.6%), followed by respiratory sepsis (19 patients; 7.0%), catheter-related bloodstream infection (14 patients; 5.2%), urinary tract infection (8 patients; 2.9%), and wound infection (6 patients; 2.2%). Eleven of these patients had two or more septic events.
Follow-up
The median follow-up was 149.9 months (range 140.1-159.7). Nine patients (3.3%) were lost to follow-up. We confirmed by reviewing data from the National Mortality Register that 7 of these 9 patients died with a median survival of 157 months after surgery. At the end of the study, 87 patients died from gastric cancer recurrence, 59 due to causes unrelated to gastric cancer, 7 from unknown causes, and 2 (one with confirmed recurrence) were lost to follow-up.
A total of 116 remained alive.
Recurrence and Risk Factors Related to the Time to Recurrence
During the follow-up period, an independent protective effect (HR 0.55, 95% CI 0.37-0.83; p = 0.004).
Sepsis on TTR and OS
Additional multivariate analyses adjusting each complication category (complications CD > II, sepsis, and intraabdominal sepsis) for patient, disease and treatment-related variables were performed using two models (Table 4) . In both models, complications CD > II, sepsis, and intraabdominal sepsis were not associated with a significantly shorter time to recurrence or worse long-term OS.
This study in 271 patients undergoing curative resection for gastric cancer does not provide evidence supporting that either postoperative complication classified as Clavien-Dindo > II or sepsis or intraabdominal sepsis had a negative effect on tumor recurrence and OS. Advanced pathologic stage, however, remained as the most powerful predictor of recurrence and survival.
Adjuvant therapy had a beneficial effect on OS.
The potential negative effect of postoperative complications and, in particular infectious complications, on long-term oncologic outcome after curative surgery for gastrointestinal cancer has been mainly examined in the setting of colorectal cancer [1] [2] [3] [4] . A recent meta-analysis demonstrated that anastomotic leakage increases the risk of local tumor recurrence and reduces long-term cancer-specific survival after curative resection for rectal cancer [1] .
Some groups have reported contradictory results especially when the impact of anastomotic leakage on tumor recurrence and survival was analyzed in patients after colonic anastomosis only.
Also, there is conflicting evidence regarding the effects of postoperative complications on long-term survival after resection for esophageal and gastric cancer. In esophageal cancer, four research groups have reported no effect of surgical complications on overall and disease-specific survival [5, [24] [25] [26] . Four other studies [6, 7, 27, 28] is not an independent prognostic factor for OS in patients having curative gastric cancer resection [31, 32] .
As complications Clavien-Dindo > II include not only infectious complications, we specifically assessed the impact of sepsis after carefully having identified all infections that induced a systemic inflammatory response syndrome, but even in this setting no impact on recurrence and long-term OS was found.
The present findings should be interpreted taking into account the limitation of the retrospective design of the study covering a 20-year period (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) ) and the relatively small series of patients. Although we are aware of the wide time span of the study and that this might include heterogeneity in the perioperative care of the patients, further adjustment per year of surgery in the multivariate models did not affect the results obtained (see models "2" in Table 4 ). It should be noted that patient data was collected prospectively by the same surgeon (M.P), surgery was performed by a reduced specialised team leaded by the same surgeon (M.P) in both institutions, and the follow-up assessment was achieved, in collaboration with the same oncologists, with a high degree of compliance during the whole study period. The potential impact of adjuvant therapy variability was limited as we mostly used the same protocol.
Taking into account the sample size and the event rate in the group of patients without postoperative complications, our study had a 80% of power to detect a 13% increase in 5-year overall survival and a 15% increase in 5-year recurrence-free survival due to complications classified as Clavien-Dindo > II.
Thus, besides the lack of a true association, the absence of a statistically significant association could be due to (i) the presence of an association smaller than those depicted above or, (ii) a type II error (20%). The apparent high mortality due to unrelated causes (59 patients) can be explained as the mean age of our patients was high at the time of surgery (almost 70 years) and the follow-up period was very long. In fact, the majority of patients died due to cardiovascular (47%) or respiratory (25%) causes. Despite the lack of an effect on recurrence and survival, a priority for improvement should be to reduce postoperative complications after curative gastric cancer surgery.
In conclusion, our results do not support the hypothesis that postoperative complications Clavien-Dindo > II, sepsis, and intraabdominal sepsis have a negative impact on the oncologic outcome after curative gastric cancer surgery, which seems to depend mostly on the pathological stage of the disease. 
